
Caitlyn Ulmer
Caitlyn Ulmer
Caitlyn is a PhD Candidate in Molecular Pharmacology and Experimental Therapeutics at the Mayo Clinic Graduate School of Biomedical Sciences, where her research focuses on cancer pharmacology and the development of targeted therapeutic strategies. Her work centers on engineering and evaluating lipid nanoparticle–based delivery systems to improve treatment efficacy and specificity in ovarian cancer.
She earned her B.S. in Pharmacology & Toxicology from Saint Joseph’s University, graduating with Dean’s List honors and membership in Alpha Sigma Nu Honor Society. During her undergraduate training, she developed strong foundations in experimental design and laboratory techniques, including cell culture, flow cytometry, and molecular biology, while conducting research that solidified her commitment to translational science.
In addition to research, Caitlyn has demonstrated leadership and communication skills through roles in academic support, science outreach, and social media initiatives. She is passionate about advancing therapeutics that bridge bench research and clinical impact, with the goal of improving outcomes for patients with cancer.




